Resources for Patients and the Public

The supply of pediatric acetaminophen and ibuprofen is currently limited due to increased demand.

Ask your pharmacist for individualized advice on children’s pain or fever medications if you have any questions.

Please see the resources below for more information about safely managing children’s pain and fever during the medication shortage:

• Healthy Parenting Winnipeg : https://healthyparentingwinnipeg.ca/limited-supply-of-fever-and-pain-medicine-products-for-children-information-for-families/
• Imported Acetaminophen for Children: Getting the Right Dose: https://safemedicationuse.ca/newsletter/downloads/202211NewsletterV13N11-Imported-Acetaminophen.pdf

On March 31, 2022, new rules for the prescribing and dispensing of tramadol come into effect. Learn more about how these changes will effect your new or existing prescription for tramadol with the following FAQ: https://cphm.ca/resource/tramadol-faq/

Due to a global shortage of infant formulas for infants with food allergies and certain medical conditions, Canada is experiencing an acute shortage of extensively hydrolyzed formula (EHF) for moderate food allergies, and amino acid formulas (AAF) for complex or severe food allergies. Some of these formulas may be available at your local pharmacy. Call your local pharmacy to ask what is in stock or if they can order it for you. At the discretion of your pharmacy, the amount of formula you can purchase at one time may be limited and it might be kept behind the pharmacy counter to protect supply. A listing of Manitoba pharmacies is available through the Pharmacy Public Register.

For additional information and suggestions, please see the following resources:

• Information for Families on the Limited Supply of Infant Formula (Health Canada)
• Limited Supply of Infant Formula (Healthy Parenting Winnipeg)

Keeping easily accessible medications and medical sharps devices (such as needles or lancets) around the house, and/or improper disposal of these products, puts family members, pets, garbage and municipal workers, janitors an housekeepers at risk of being harmed.

The Health Products Stewardship Association in partnership with Manitoba’s community pharmacies, developed return programs for unused medications and used medical sharps devices.

To learn more about proper disposal of unused medications, please visit https://healthsteward.ca/returning-medications/

To learn more about proper disposal of used medical sharps devices such as needles or lancets, please visit https://healthsteward.ca/returning-medical-sharps/

The following resources an help you be an active partner in your healthcare to keep yourself safe when using prescription and non-prescription medications:

• Facts for Patients and the Public about Safety IQ
• 5 Questions to Ask about Your Medications
• SafeMedicationUse.ca
• What information is in a prescription?
• One Simple Solution for Medication Safety
• It’s Safe to Ask

Naloxone is a life-saving drug that can temporarily reverse the effects of an opioid overdose and it is available in Manitoba without a prescription. Naloxone may be sold behind a pharmacy counter or in the retail area of the store. Ask your pharmacist where you can find naloxone.

In keeping with our mandate to protect the public interest, CPhM provides a listing of community pharmacies that sell naloxone products including injectable and nasal spray products.

Note: Naloxone sale information is self-declared by pharmacy managers on behalf of their stores. Availability and price may vary. Please contact the pharmacy or pharmacies of your choice for naloxone availability and price.

Once you buy a naloxone kit, a pharmacist can teach you how to use the kit in an opioid overdose emergency.

If you need a publicly funded (free) naloxone kit, please contact Street Connections.

If you need help with an addiction, you can call the Manitoba Addictions Helpline at 1-855-662-6605, or visit http://mbaddictionhelp.ca/ 

The following resources will provide you with additional information about opioid overdose and naloxone:

Giving Naloxone by Injection

How to Inject Naloxone (video)

How to Inject Naloxone (Ampoules) (Print)

How to Inject Naloxone (Vials) (Print)

Giving Naloxone by Nasal Spray

How to Give Naloxone Nasal Spray (Video)

How to Use Naloxone Nasal Spray (Print)

Opioid Overdose and Naloxone Training Modules (Free)

Toward the Heart Naloxone Administration: https://towardtheheart.com/naloxone-course

As of September 1, 2022, injection-certified pharmacists can give COVID-19 and seasonal flu vaccines to children two (2) years of age and older.

At this time, certified pharmacists can only give COVID-19 vaccines and flu vaccines that are part of Manitoba’s annual Seasonal Influenza Immunization Program to children two (2) years of age and older.

For all other vaccines, the age of administration remains at age seven (7) years and older.

Availability of COVID-19 and flu vaccines may be limited and can vary from pharmacy to pharmacy. Contact your local pharmacy for availability or use the Government of Manitoba Vaccine Finder to search for a provider:  https://protectmb.ca/covid-19-vaccine

As of November 23, 2021, a new Ministerial Order under The Regulated Health Professions Act allows pharmacists to perform and interpret rapid antigen tests and rapid molecular (non-PCR) COVID-19 tests for Manitobans for any reason. This new order replaces the previous one that only permitted rapid testing for travel purposes.

The COVID-19 rapid antigen tests may be self-administered by the person seeking the test or administered by the pharmacist and conducted within the pharmacy facility, with pharmacist test interpretation, communication of diagnosis, and documentation provided.

Contact your local pharmacy to ask if they provide this service.

Health Canada is advising Canadians not to use either the veterinary or human drug versions of Ivermectin to prevent or treat COVID-19.

There is no evidence to support the use of Ivermectin as a safe or effective way to treat or prevent COVID-19. In fact, Ivermectin (especially when it is prepared for use in livestock) can be dangerous to people and may cause serious health problems including vomiting, diarrhea, low blood pressure, allergic reactions, dizziness, seizures, coma and even death.

If you have purchased Ivermectin for the prevention or treatment of COVID-19:

• stop using it and discard it by returning the product to the point of sale or any pharmacy for proper disposal
• consult a healthcare professional if you have used Ivermectin and have health concerns
• report any side effectsfrom this product directly to Health Canada
• submit a complaint to Health Canada should you have any information regarding the illegal advertising or sale of ivermectin or any other health product using its online complaint form

Protectmb.ca is a Government of Manitoba website that can provide you with up-to-date information about the provincial COVID-19 vaccination campaign. The website ensures you have easy access to eligibility criteria, immunization sites, and myth-busting information.

Visit protectmb.ca for more information.

A recent SafeMedicationUse.ca newsletter shared tips with consumers to help them safely receive a COVID-19 vaccine. With the continuing evolution of vaccine guidance, as reported and widely discussed in the media, you may have questions about whether the vaccine is safe for you. For more information COVID-19 vaccines and how you can improve your safety, please see the following link:

https://safemedicationuse.ca/newsletter/COVID-19-vaccine.html

You do not need to stockpile medications.

Speak to your pharmacist if you are worried about your medication supply. Older adults and those with underlying health conditions may wish to speak with their pharmacist about a prescription refill, so they do not have to go to a pharmacy if they do become sick.

If you are feeling unwell and require medications, call your pharmacy and they will arrange to provide you with the medications you need.

Please see the Health Canada notice advising Canadians to help support the continued supply of medication.

Chloroquine and hydroxychloroquine may cause serious side effects, including serious heart rhythm problems. The risk of these side effects may increase at higher doses, or if the drugs are used in combination with other drugs, such as the antibiotic azithromycin. Patients should use these drugs only under the supervision of a physician.

Please see the Health Canada notice on Chloroquine and Hydroxychloroquine.